<!DOCTYPE html>
<!--[if lt IE 7]>      <html class="no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]-->
<!--[if IE 7]>         <html class="no-js lt-ie9 lt-ie8"> <![endif]-->
<!--[if IE 8]>         <html class="no-js lt-ie9"> <![endif]-->
<!--[if gt IE 8]><!--><html class="no-js"> <!--<![endif]-->
    <head>
        <meta charset='utf-8'>
        <meta http-equiv='X-UA-Compatible' content='IE=edge,chrome=1'>
        <title>DC Code - § 7-1305.06c. Psychotropic medication review.</title>
        <meta name='description' content='A simple, free browser for the Washington, DC Code'>
        <meta name='viewport' content='width=device-width'>
        <link href='http://fonts.googleapis.com/css?family=Open+Sans:400italic,700italic,400,700' rel='stylesheet' type='text/css'>
        <link rel='stylesheet' type='text/css' href='/simple/css/reset.css' media='screen' />
        <link rel='stylesheet' type='text/css' href='/simple/css/site.css' media='screen' />
        <link rel='stylesheet' type='text/css' href='/simple/css/body.css' media='screen' />
        <link rel='stylesheet' type='text/css' href='/simple/css/print.css' media='print' />
        <link rel='stylesheet' type='text/css' href='/simple/css/icons/style.css' media='screen' />
    </head>
    <body>
        <div class="container">
            <header>
                <div class='right'>
                    <form id='search-form'>
                        <input id='search-box' type='text' placeholder="15-101"
                        /><button id='search-button'><span class="icon-search"></span></button>
                    </form>
                </div>
                <p id='sitename'>Code of the District of Columbia (Unofficial)</p>
            </header>

            <div class="clearfix" style="width: 100%;">

            <div id='sidebar' class='col4'>
                
                    <h2>You Are Here</h2>
                    <ul class="ancestors">
                    
                        <li><a href="/simple">Code of the District of Columbia</a></li>
                    
                        <li>↪ <a href="/simple/Title-7">Title 7. Human Health Care and Safety</a></li>
                    
                        <li>↪ <a href="/simple/Title-7/Chapter-13">Chapter 13. Citizens with Intellectual Disabilities</a></li>
                    
                        <li>↪ <a href="/simple/Title-7/Chapter-13/Subchapter-V">Subchapter V. Rights of Persons with Intellectual Disabilities</a></li>
                    
                    <li>↪ § 7-1305.06c. Psychotropic medication review.</a></li>
                    </ul>
                

                
                    <h2>Previous Section</h2>
                    <p><a href="/simple/sections/7-1305.06b.html">§ 7-1305.06b. Review panel for administration of psychotropic medications.</a>
                

                
                    <h2>Next Section</h2>
                    <p><a href="/simple/sections/7-1305.07~P.html">§ 7-1305.07. Essential surgery in medical emergency. [Repealed]</a>
                

                <h2>Current as of...</h2>
                <p class="recency">December 13, 2013 and through D.C. Act 20-210 (except D.C. Acts 20-130, 20-157, and 20-204)</p>
            </div>
            <div class='col8'>
                <div id='content'>
                    <h1>§ 7-1305.06c. Psychotropic medication review.</h1>


     

    

    

    <div class="primary-content"> 

    
        <p class=" has-level-num " style="padding-left: 0em">
            
                
                    <span class="level-num" style="">(a) </span>
                
                    <span class="" style="">By April 15, 2009, the DDS shall complete a psychotropic medication review for all individuals served by DDS.</span>
                
            
        </p>
    
        <p class=" has-level-num " style="padding-left: 0em">
            
                
                    <span class="level-num" style="">(b) </span>
                
                    <span class="" style="">By October 17, 2008, the DDS shall establish written procedures, which shall include timelines and shall identify responsible entities or individuals, for promptly implementing the recommendations for each individual identified by the psychotropic medication review.</span>
                
            
        </p>
    
        <p class=" has-level-num " style="padding-left: 0em">
            
                
                    <span class="level-num" style="">(c) </span>
                
                    <span class="" style="">The psychotropic medication review shall be conducted by a review team that includes professionals with expertise in the prescription, use, and side effects of psychotropic medications as therapy for individuals who have been dually diagnosed with intellectual disabilities and mental illness.</span>
                
            
        </p>
    
        <p class=" has-level-num " style="padding-left: 0em">
            
                
                    <span class="level-num" style="">(d) </span>
                
                    <span class="" style="">DDS shall establish in writing:</span>
                
            
        </p>
    
        <p class=" has-level-num " style="padding-left: 2.25em">
            
                
                    <span class="level-num" style="">(1) </span>
                
                    <span class="" style="">Procedures for an initial administrative review of psychotropic medication prescriptions for all individuals served by DDS.</span>
                
            
        </p>
    
        <p class=" has-level-num " style="padding-left: 2.25em">
            
                
                    <span class="level-num" style="">(2) </span>
                
                    <span class="" style="">Procedures and criteria for determining which individuals receive only an initial administrative review of psychotropic medications, and which individuals also receive a more detailed clinical review of psychotropic medications; and</span>
                
            
        </p>
    
        <p class=" has-level-num " style="padding-left: 2.25em">
            
                
                    <span class="level-num" style="">(3) </span>
                
                    <span class="" style="">Criteria for screening and determining the clinical appropriateness of each psychotropic medication prescribed for each individual.</span>
                
            
        </p>
    
        <p class=" has-level-num " style="padding-left: 0em">
            
                
                    <span class="level-num" style="">(e) </span>
                
                    <span class="" style="">The review team shall complete the initial administrative review of psychotropic medications. The initial administrative review of psychotropic medications shall determine, at minimum, for each individual served by DDS:</span>
                
            
        </p>
    
        <p class=" has-level-num " style="padding-left: 2.25em">
            
                
                    <span class="level-num" style="">(1) </span>
                
                    <span class="" style="">All prescribed psychotropic medications;</span>
                
            
        </p>
    
        <p class=" has-level-num " style="padding-left: 2.25em">
            
                
                    <span class="level-num" style="">(2) </span>
                
                    <span class="" style="">The diagnosis justifying each prescription;</span>
                
            
        </p>
    
        <p class=" has-level-num " style="padding-left: 2.25em">
            
                
                    <span class="level-num" style="">(3) </span>
                
                    <span class="" style="">The provision of informed consent for each prescription;</span>
                
            
        </p>
    
        <p class=" has-level-num " style="padding-left: 2.25em">
            
                
                    <span class="level-num" style="">(4) </span>
                
                    <span class="" style="">The presence of an accompanying behavioral plan; and</span>
                
            
        </p>
    
        <p class=" has-level-num " style="padding-left: 2.25em">
            
                
                    <span class="level-num" style="">(5) </span>
                
                    <span class="" style="">Any other mental health services being provided to the individual.</span>
                
            
        </p>
    
        <p class=" has-level-num " style="padding-left: 0em">
            
                
                    <span class="level-num" style="">(f) </span>
                
                    <span class="" style="">The review team shall conduct a clinical review of psychotropic medications when the initial administrative review meets the review team&#39;s criteria indicating that a detailed clinical review of the individual&#39;s psychotropic medication is warranted. The clinical review shall seek to determine the clinical appropriateness of each prescribed psychotropic medication and the potential for alternative approaches. The clinical review shall include, at a minimum, interviews with the individual, the prescribing professional, and the individual&#39;s residential and day service providers, if any.</span>
                
            
        </p>
    
        <p class=" has-level-num " style="padding-left: 0em">
            
                
                    <span class="level-num" style="">(g) </span>
                
                    <span class="" style="">By no later than 30 days after completing a psychotropic medication review of an individual, the review team shall issue a written report, which shall include recommendations for:</span>
                
            
        </p>
    
        <p class=" has-level-num " style="padding-left: 2.25em">
            
                
                    <span class="level-num" style="">(1) </span>
                
                    <span class="" style="">Continued use, modification, or termination of psychotropic medication;</span>
                
            
        </p>
    
        <p class=" has-level-num " style="padding-left: 2.25em">
            
                
                    <span class="level-num" style="">(2) </span>
                
                    <span class="" style="">Potential use of alternative approaches, including therapies, behavioral plans, skill development, and environmental modifications;</span>
                
            
        </p>
    
        <p class=" has-level-num " style="padding-left: 2.25em">
            
                
                    <span class="level-num" style="">(3) </span>
                
                    <span class="" style="">Informed consent, if informed consent has not been provided; and</span>
                
            
        </p>
    
        <p class=" has-level-num " style="padding-left: 2.25em">
            
                
                    <span class="level-num" style="">(4) </span>
                
                    <span class="" style="">Development of a behavioral plan, if no behavioral plan is present.</span>
                
            
        </p>
    
        <p class=" has-level-num " style="padding-left: 0em">
            
                
                    <span class="level-num" style="">(h) </span>
                
                    <span class="" style="">A copy of the written report of the review team shall be appended to the individual&#39;s individual habilitation plan and shall be provided to:</span>
                
            
        </p>
    
        <p class=" has-level-num " style="padding-left: 2.25em">
            
                
                    <span class="level-num" style="">(1) </span>
                
                    <span class="" style="">The individual;</span>
                
            
        </p>
    
        <p class=" has-level-num " style="padding-left: 2.25em">
            
                
                    <span class="level-num" style="">(2) </span>
                
                    <span class="" style="">The individual&#39;s legal representative, if any;</span>
                
            
        </p>
    
        <p class=" has-level-num " style="padding-left: 2.25em">
            
                
                    <span class="level-num" style="">(3) </span>
                
                    <span class="" style="">The individual&#39;s advocate for a person with an intellectual disability, if any;</span>
                
            
        </p>
    
        <p class=" has-level-num " style="padding-left: 2.25em">
            
                
                    <span class="level-num" style="">(4) </span>
                
                    <span class="" style="">The individual&#39;s DDS case manager;</span>
                
            
        </p>
    
        <p class=" has-level-num " style="padding-left: 2.25em">
            
                
                    <span class="level-num" style="">(5) </span>
                
                    <span class="" style="">Other persons identified in the individual&#39;s individual habilitation plan as reasonably available, mentally capable, and willing to provide substituted consent pursuant to D.C. Official Code <a href='/simple/sections/21-2210.html'>§ 21-2210</a>, if any;</span>
                
            
        </p>
    
        <p class=" has-level-num " style="padding-left: 2.25em">
            
                
                    <span class="level-num" style="">(6) </span>
                
                    <span class="" style="">The individual&#39;s residential service provider; and</span>
                
            
        </p>
    
        <p class=" has-level-num " style="padding-left: 2.25em">
            
                
                    <span class="level-num" style="">(7) </span>
                
                    <span class="" style="">The Quality Trust for Individuals with Disabilities, Inc.</span>
                
            
        </p>
    

    </div>

    <div class="annotations"> 

    
        <p class="subheading " style="padding-left: 2.25em">
            
                
                    <span class="level-heading" style="">History</span>
                
            
        </p>
    
        <p class=" " style="padding-left: 2.25em">
            
                
                    <span class="" style="">(Mar. 3, 1979, <a href='http://openlims.org/public/L2-137.pdf'>D.C. Law 2-137</a>, § 506c, as added Oct. 22, 2008, <a href='http://openlims.org/public/L17-249.pdf'>D.C. Law 17-249</a>, § 5(d), 55 DCR 9206; Sept. 26, 2012, <a href='http://openlims.org/public/L19-169.pdf'>D.C. Law 19-169</a>, § 17(kk), <a href='http://www.dcregs.dc.gov/Gateway/IssueList.aspx?IssueYear=2012'>59 DCR 5567</a>.)</span>
                
            
        </p>
    
        <p class="subheading " style="padding-left: 2.25em">
            
                
                    <span class="level-heading" style="">Effect of Amendments</span>
                
            
        </p>
    
        <p class=" " style="padding-left: 2.25em">
            
                
                    <span class="" style="">The 2012 amendment by <a href='http://openlims.org/public/L19-169.pdf'>D.C. Law 19-169</a> substituted &quot;all individuals served by DDS&quot; for &quot;all DDS customers&quot; in (a) and (d)(1); substituted &quot;individual&quot; for &quot;customer&quot; or variants throughout the section; substituted &quot;intellectual disabilities&quot; for &quot;mental retardation&quot; in (c); substituted &quot;each individual served by DDS&quot; for &quot;each DDS customer&quot; in the introductory language of (e); substituted &quot;advocate for a person with an intellectual disability&quot; for &quot;mental retardation advocate&quot; wherever it appears in the section; and in (h)(5), substituted &quot;Other persons&quot; for &quot;The individuals&quot;.</span>
                
            
        </p>
    
        <p class="subheading " style="padding-left: 2.25em">
            
                
                    <span class="level-heading" style="">Temporary Addition of Section</span>
                
            
        </p>
    
        <p class=" " style="padding-left: 2.25em">
            
                
                    <span class="" style="">For temporary (225 day) addition, see § 4(d) of Health-Care Decisions for Persons with Mental Retardation and Developmental Disabilities Temporary Amendment Act of 2006 (<a href='http://openlims.org/public/L16-194.pdf'>D.C. Law 16-194</a>, March 2, 2007, law notification 54 DCR 2492).</span>
                
            
        </p>
    
        <p class=" " style="padding-left: 2.25em">
            
                
                    <span class="" style="">For temporary (225 day) addition, see § 4(d) of Health-Care Decisions for Persons with Mental Retardation and Developmental Disabilities Temporary Amendment Act of 2007 (<a href='http://openlims.org/public/L17-100.pdf'>D.C. Law 17-100</a>, February 2, 2008, law notification 55 DCR 3407).</span>
                
            
        </p>
    
        <p class="subheading " style="padding-left: 2.25em">
            
                
                    <span class="level-heading" style="">Emergency Legislation</span>
                
            
        </p>
    
        <p class=" " style="padding-left: 2.25em">
            
                
                    <span class="" style="">For temporary (90 day) addition, see § 4(d) of Health-Care Decisions for Persons with Developmental Disabilities Emergency Amendment Act of 2006 (D.C. Act 16-480, September 25, 2006, 53 DCR 7940).</span>
                
            
        </p>
    
        <p class=" " style="padding-left: 2.25em">
            
                
                    <span class="" style="">For temporary (90 day) addition, see § 4(d) of Health-Care Decisions for Persons with Developmental Disabilities Congressional Review Emergency Amendment Act of 2006 (D.C. Act 16-566, December 19, 2006, 53 DCR 10272).</span>
                
            
        </p>
    
        <p class=" " style="padding-left: 2.25em">
            
                
                    <span class="" style="">For temporary (90 day) addition, see § 4(d) of Health-Care Decisions for Persons with Developmental Disabilities Emergency Act of 2007 (D.C. Act 17-161, October 18, 2007, 54 DCR 10932).</span>
                
            
        </p>
    
        <p class=" " style="padding-left: 2.25em">
            
                
                    <span class="" style="">For temporary (90 day) addition, see § 4(d) of Health-Care Decisions for Persons with Developmental Disabilities Congressional Review Emergency Amendment Act of 2008 (D.C. Act 17-245, January 23, 2008, 55 DCR 1230).</span>
                
            
        </p>
    
        <p class=" " style="padding-left: 2.25em">
            
                
                    <span class="" style="">For temporary (90 day) addition, see § 5(d) of Health-Care Decisions for Persons with Developmental Disabilities Emergency Act of 2008 (D.C. Act 17-492, August 4, 2008, 55 DCR 9167).</span>
                
            
        </p>
    
        <p class="subheading " style="padding-left: 2.25em">
            
                
                    <span class="level-heading" style="">Legislative History of Law 17-249</span>
                
            
        </p>
    
        <p class=" " style="padding-left: 2.25em">
            
                
                    <span class="" style="">For Law 17-249, see notes following <a href='/simple/sections/7-1203.03.html'>§ 7-1203.03</a>.</span>
                
            
        </p>
    
        <p class="subheading " style="padding-left: 2.25em">
            
                
                    <span class="level-heading" style="">Legislative History of Law 19-169</span>
                
            
        </p>
    
        <p class=" " style="padding-left: 2.25em">
            
                
                    <span class="" style="">See note to <a href='/simple/sections/7-1305.01.html'>§ 7-1305.01</a>.</span>
                
            
        </p>
    
        <p class="subheading " style="padding-left: 2.25em">
            
                
                    <span class="level-heading" style="">Editor's Notes</span>
                
            
        </p>
    
        <p class=" " style="padding-left: 2.25em">
            
                
                    <span class="" style="">Section 35 of <a href='http://openlims.org/public/L19-169.pdf'>D.C. Law 19-169</a> provided that no provision of the act shall impair any right or obligation existing under law.</span>
                
            
        </p>
    

    </div>



                </div>
            </div>
            </div>
            <footer>
                <p>This is a fast, unofficial interface to the
                <a href='http://dccouncil.us/UnofficialDCCode'>Unofficial DC Code</a> by
                <a href='https://github.com/openlawdc'>openlawdc</a>.
                Please <a href='https://github.com/openlawdc/simple-generator/issues'>report issues</a>.</p>
            </footer>
        </div>
        <script>
        ROOTDIR = "/simple";
        </script>
        <script src='/simple/js/jquery-1.11.0.min.js'></script>
        <script src='/simple/js/search.js'></script>
    </body>
</html>
